Abstract CE-43 Table 1 Multivariate Model for Neurological Manifestations During Follow-Up

VariableParameter EstimateStandard ErrorChi-Squarep-valueHazard Ratio representsHazard Ratio95% CI Hazard Ratio
0.531320.1443813.54210.0002Mestizo vs. White1.7011.2822.258
Etnia (African Latin American)0.166470.227460.53570.4642ALA vs. White1.1810.7561.845
Etnia (Other)0.315900.424540.55370.4568Other vs. White1.3710.5973.152
Disease Duration at Cohort Entry (Up to 6 Months)−0.326790.207642.47690.1155Up to 6 Months vs. Entered at Diagnosis0.7210.4801.083
Disease Duration at Cohort Entry (6 to 12 months)−0.327040.207262.48980.11466 to 12 Months vs. Entered at Diagnosis0.7210.4801.082
Disease Duration at Cohort Entry (13 to 24 months)−0.443890.191685.36290.020613 to 24 Months vs. Entered at Diagnosis0.6420.4410.934
Myalgias/Myositis0.605510.1616914.02350.0002Yes vs. No1.8321.3352.515
Pneumonitis0.906630.420764.64290.0312Yes vs. No2.4761.0855.648
Shrunk lung0.887270.416484.53870.0331Yes vs. No2.4281.0745.493
Hemolytic Anemia0.487760.186456.84360.0089Yes vs. No1.6291.1302.347